Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001641172-25-005519

Options or other derivatives

  • CEO acquired 0 shares (option exercise)
  • CEO acquired 9,438 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pershing Edward · CEO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-04-19 Exercise or conversion : show line 1 in the form 8% Unsecured Convertible Promissory Note −0 D
2025-04-19 Exercise or conversion : show line 2 in the form Series D-1 Convertible Preferred Stock +9,438 2,072,976 D
Loading xslF345X05/ownership.xml…